COP
36
2
LRCX
56
4
AMGN
42
14
CA
19
6
LEG
16
2
SJM
17
5
CI
35
2
GE
60
5
UAL
73
3
AMAT
33
3
CMS
57
2
XRX
48
2
PDCO
77
3
CCL
68
6
DLTR
52
8
UNH
42
6
HP
44
14
AMT
30
2
PCG
59
9
ABBV
40
5
COP
36
2
LRCX
56
4
AMGN
42
14
CA
19
6
LEG
16
2
SJM
17
5
CI
35
2
GE
60
5
UAL
73
3
AMAT
33
3
CMS
57
2
XRX
48
2
PDCO
77
3
CCL
68
6
DLTR
52
8
UNH
42
6
HP
44
14
AMT
30
2
PCG
59
9
ABBV
40
5
Financhill
Back

Bristol-Myers Squibb 10K Form

Sell
40

BMY
Bristol-Myers Squibb

Last Price:
$57.30
Seasonality Move:
1.66%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BMY News And Ratings

See the #1 stock for the next 7 days that we like better than BMY

BMY Financial Statistics

Sales & Book Value

Annual Sales: $45B
Cash Flow: $5.3B
Price / Cash Flow: 8.43
Annual Sales: $8.45
Price / Book: 6.78

Profitability

EPS (TTM): -3.59000
Net Income (TTM): $-7.3B
Gross Margin: $34.3B
Return on Equity: -33.18%
Return on Assets: -7.66%

Bristol-Myers Squibb Earnings Forecast

Key Bristol-Myers Squibb Financial Ratios

  • The Gross Profit Margin over the past 37 years for BMY is 76.24%.
  • The Selling, General & Administrative Expenses for BMY have been equal to 17.27% of Gross Profit Margin.
  • The Research & Development expenses have been 20.66% of Revenue.
  • The Interest Expense is 14.53% of Operating Income.
  • The Net Earning history of BMY is 17.83% of Total Revenues.
  • Per Share Earnings over the last 37 years have been positive in 18 years.

Bristol-Myers Squibb Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: BMY
CUSIP: 110122
Website: bms.com

Debt

Debt-to-Equity Ratio: 2.9
Current Ratio: 1.24
Quick Ratio: 1.02

Price-to-Earnings

Trailing P/E Ratio: 14.85
Forward P/E Ratio: 8.1

BMY Technical Analysis vs Fundamental Analysis

Sell
40
Bristol-Myers Squibb (BMY) is a Sell

Is Bristol-Myers Squibb a Buy or a Sell?